June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
A Novel Index to Define the Rate of Visual Field Change in Glaucoma
Author Affiliations & Notes
  • lilian mohamed
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Esteban Morales
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Nucharee Parivisutt
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Pradtana Hirunpatravong
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Reza Alizadeh
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Fei Yu
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Abdelmonem Afifi
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Kouros Nouri-Mahdavi
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Joseph Caprioli
    glaucoma, jules stein eye institute, Los angeles, California, United States
  • Footnotes
    Commercial Relationships   lilian mohamed, None; Esteban Morales, None; Nucharee Parivisutt, None; Pradtana Hirunpatravong, None; Reza Alizadeh, None; Fei Yu, None; Abdelmonem Afifi, None; Kouros Nouri-Mahdavi, None; Joseph Caprioli, None
  • Footnotes
    Support  NIH 1K23EY022659, RPB
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4741. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      lilian mohamed, Esteban Morales, Nucharee Parivisutt, Pradtana Hirunpatravong, Reza Alizadeh, Fei Yu, Abdelmonem Afifi, Kouros Nouri-Mahdavi, Joseph Caprioli; A Novel Index to Define the Rate of Visual Field Change in Glaucoma. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4741.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To present a novel method (Progression Index) to measure the rate of glaucomatous VF progression on a normalized scale, and throughout the entire perimetric range.

Methods : In this retrospective, longitudinal, observational study, 8,486 eyes of 4,610 glaucomatous patients with a minimum of 6 visual fields (VF) and 3 years of follow up were included. To reduce noise, all threshold values in a series for a test location with Cook’s distance >1 or Studentized residuals >3 were removed. VF locations were partitioned into “decay exponential” or “improvement exponential” models, depending on the a prior linear trend. The Standardized Percentage Rate of Change (SPRoC) for each location was calculated. Criteria for statistically and clinically significant change at each location required the slope to be 1) beyond the 95% confidence interval, and 2) > three times the normal aging rate. A normalized Progression Index (PI) was calculated for each eye based on the sum of the SPRoC for decaying and improving locations with boundaries for maximum and minimum rates set by simulated VF series. The PI was normalized from -1 to 1 where -1 is fastest decay, 0 is no change, and 1 is fastest improvement. Eyes with PI scores of < −0.03 were categorized as progressors and those with PI < −0.14 were considered fast progressors; these values were based on an ROC curve from a separate VF database of expert evaluations of serial VFs.

Results : The total number of VF exams was 89,704 with 425,039 test locations. A total of 2.8% of locations were removed. The proportion of decay, no change, and improvement for individual locations were 5.6%, 93.7%, and 0.7%, respectively. The mean SPRoC for the decay, no change, and improvement test locations were −5.0 (±5.6) %/year, and −0.6 (±2.5) %/year, and 4.5 (±3.7) %/year, respectively. These rates refer to the % of the entire perimetric range lost per year. A total of 1,801 (21.2%) eyes were categorized as progressors and 453 (5.3%) were categorized as fast progressors.

Conclusions : This method provides a normalized index for approximating the rates of worsening (or improvement) of serial perimetric measurements in glaucomatous eyes. The PI is designed to represent statistically and clinically significant change, operates over the entire perimetric range, and can be used to identify those patients who are fast progressors.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×